OneSource partners with Formycon for biosimilars manufacturing

OneSource partners with Formycon for biosimilars manufacturing. Onesource Specialty Pharma has entered a strategic manufacturing partnership with Germany’s Formycon AG to produce biosimilars. The collaboration aims to leverage Formycon’s technology and Onesource’s production capabilities. No financial terms of the deal were disclosed.

📊 STOCKS: ONESOURCE | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #Biosimilars